WebView Sudhir Chandna's business profile as Sc G and Additional Director at Drdo. Find contact's direct phone number, email address, work history, and more. WebDr. Sudhir Chandna works on insect cell radio-resistance, low-dose hyper-radio sensitivity and the unusual radiation responses of natural systems. Moola Joghee Nanjan Prof. M. J. Nanjan’s interests include drug design/development, natural products and radio-protection.
DRDO
Web9 May 2024 · Dr Sudhir Chandna, Institute of Nuclear Medicine and Allied Sciences (INMAS) scientist, on Sunday said the recently approved anti-COVID drug 2-deoxy-D-glucose (2-DG) … Web15 May 2024 · A lab of Defence Research and Development Organisation INMAS had developed this anti-COVID drug 2-deoxy-D-glucose (2-DG). It is revealed that it is completely safe and will help patients recover faster, Dr Sudhir Chandna, Institute of Nuclear Medicine and Allied Sciences (INMAS) scientist, had said last Sunday. safest region in united states
Covid-19: First batch of 2-deoxy-D-glucose drug to be launched next …
Web18 May 2024 · Asked about the pricing of the drug, Dr Sudhir Chandna of DRDO has said it will depend on the scale of production. "Those factors are with Dr Reddy's Laboratories … Web9 May 2024 · Amid speculations over the efficacy of the anti-COVID drug developed by DRDO, Dr Sudhir Chandna, a scientist at Institute of Nuclear Medicine and Allied Sciences … WebShubhra CHATURVEDI, Scientist E- INMAS Cited by 372 of Defence Research and Development Organisation, Delhi (DRDO) Read 51 publications Contact Shubhra … safest reliable used cars